Synapse - Owen O'connor

Search Within

Owen O'connor

Results (98)

Clinical responses in multiple myeloma and waldenstrom's macroglobulinemia with the proteasome inhibitor carfilzomib (PR-171)

Meeting Abstract

Alsina, M.; O'Connor, O. A.; Stewart, A. K.; Trudel, S.; Urquilla, P. R.; Vallone, M. K.; Molineaux, C. J.; Goy, A.; Orlowski, R. Z.
Haematologica (2007)

Fulltext@MSK | Save

Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma

Journal Article

O'Connor, O. A.; Hamlin, P. A.; Portlock, C.; Moskowitz, C. H.; Noy, A.; Straus, D. J.; Macgregor-Cortelli, B.; Neylon, E.; Sarasohn, D.; Dumetrescu, O.; more...
British Journal of Haematology (2007)

Fulltext@MSK | Save

Bortezomib disrupts tumour-dendritic cell interactions in myeloma and lymphoma: Therapeutic implications

Journal Article

Kukreja, A.; Hutchinson, A.; Mazumder, A.; Vesole, D.; Angitapalli, R.; Jagannath, S.; O'Connor, O. A.; Dhodapkar, M. V.
British Journal of Haematology (2007)

Fulltext@MSK | Save

FDG-PET Lymphoma Demonstration Project Invitational Workshop

Journal Article

Kelloff, G. J.; Sullivan, D. M.; Wilson, W.; Cheson, B.; Juweid, M.; Mills, G. Q.; Zelenetz, A. D.; Horning, S. J.; Weber, W.; Sargent, D. J.; more...
Academic Radiology (2007)

Fulltext@MSK | Save

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas

Journal Article

Aghajanian, C.; Burris, H. A. 3rd; Jones, S.; Spriggs, D. R.; Cohen, M. B.; Peck, R.; Sabbatini, P.; Hensley, M. L.; Greco, F. A.; Dupont, J.; more...
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Multicenter phase I studies to evaluate the safety, tolerability, and clinical response to intensive dosing with the proteasome inhibitor PR-171 in patients with relapsed or refractory hematological malignancies

Meeting Abstract

O'Connor, O. A.; Orlowski, R. Z.; Alsina, M.; Stewart, K.; Trudel, S.; Vallone, M. K.; Woo, T. M.; Urquilla, P. R.; Molineaux, C. J.; Goy, A.
Blood (2006)

Fulltext@MSK | Save

Pralatrexate (PDX) produces durable complete remissions in patients with chemotherapy resistant precursor and peripheral T-Cell lymphomas: Results of the MSKCC phase I/II experience

Meeting Abstract

O'Connor, O. A.; Hamlin, P. A.; Gerecitano, J.; Portlock, C. S.; Noy, A.; Moskowitz, C.; Straus, D. J.; Sarasohn, D.; Dumitrescu, O.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

Early phase experience with pralatrexate (10-propargyl-10-deazaaminopterin [PRX]), a novel antifolate with high affinity for the reduced folate carrier, in patients with chemotherapy refractory lymphoproliferative malignancies

Meeting Abstract

O'connor, O.; Hamlin, P.; Neylon, E.; Moskowitz, C.; Portlock, C.; Noy, A.; Sirotnak, F.; Zelenetz, A.; Mould, D.; Horwitz, S.
EJC Supplements (2006)

Fulltext@MSK | Save

Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL

Meeting Abstract

Moskowitz, C.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; O'Connor, O. A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; Lessac-Chenen, S.; Weaver, A.; more...
Blood (2006)

Fulltext@MSK | Save

FDG-PET scans as a staging study for T-cell lymphomas: High rates of positivity do not result in frequent changes in stage

Meeting Abstract

Horwitz, S. M.; Foss, F.; Goldfarb, S.; Molina, A.; Hamlin, P. A.; O'Connor, O. A.; Cammarata, M.; Moskowitz, C. H.; Zelenetz, A. D.
Blood (2006)

Fulltext@MSK | Save